Puzzle Medical announced today that it closed a Series A funding round worth approximately $25 million (CAN$34 million).
Cordis-X, a cardiovascular-focused investment vehicle, led the funding round. Ajax Health, Hellman & Friedman and KKR back Cordis-X. Longview Ventures, Desjardins Capital and BDC Capital’s Thrive Venture Fund participated, too, along with existing investors.
“We are thrilled to have closed our Series A funding round and to have the support of such a renowned syndicate of investors,” said Jade Doucet-Martineau, co-founder and CEO of Puzzle Medical Devices. “This milestone achievement is a reﬂection of the team’s dedication and execution capability and will allow us to continue to execute on our mission of transforming the treatment of advanced heart failure.”
Montreal, Quebec–based Puzzle Medical is developing a long-term, percutaneous, transcatheter heart pump for people with advanced heart failure. With a modular design, the…